TY  - GEN
T1  - Diagnostic, Prognostic and Predictive Biological Markers in Bladder Cancer – Illumination of a Vision 2.0
A2  - Ecke, Thorsten
LA  - eng
PB  - MDPI - Multidisciplinary Digital Publishing Institute
YR  - 2021
UL  - https://ebooks.jgu.edu.in/Record/doab-20.500.12854-68385
AB  - After our successful first Special Issue about bladder cancer, we proceeded with the second issue. Again, many international scientists submitted their newest research results in that extremely interesting field and followed our call for submissions. It is not only the collection and combination of old and new markers that could develop new possibilities, but also the focus on different classifications and sub-classifications that will unveil new ways in diagnostic and therapeutic approaches. It seems that the two established diagnostic tools will still play an important role, but new markers and diagnostics tools will present more detailed and more differentiated possibilities in the treatment of urinary bladder cancer. This second Special Issue is full of scientific results that could provide new ways to help patients with instruments for early diagnostics and with predictive and prognostic markers on their way to finding new and personalized strategies for therapy. The editors thank all of the submitting authors for their efforts and time spent on each manuscript. We hope that this Special Issue will prove useful to research work in bladder cancer in the future. We hope that many talented researchers will use multiple forms of art to improve their professional successes and to ameliorate diagnostics and therapy in bladder cancer.
SN  - 9783039436859
SN  - 9783039436866
KW  - Metallothionein
KW  - urothelium
KW  - urothelial cancer
KW  - cadmium exposure
KW  - zinc transporter
KW  - bladder
KW  - TAGLN
KW  - F-actin
KW  - PTEN
KW  - p53
KW  - tumorigenesis
KW  - proliferation
KW  - invasion
KW  - TERT promoter mutations
KW  - FGFR3
KW  - non muscle invasive bladder cancer
KW  - BCG therapy
KW  - bladder cancer
KW  - JAK-STAT pathway
KW  - combination therapy
KW  - oncolytic adenovirus
KW  - virotherapy
KW  - STAT3/5 inhibitor
KW  - JAK inhibitor
KW  - XVir-N-31
KW  - bladder cancer detection
KW  - urinary biomarkers
KW  - DNA methylation
KW  - ECRG4
KW  - ITIH5
KW  - n/a
KW  - biomarker
KW  - cancer
KW  - grade
KW  - metabolomics
KW  - MS
KW  - NMR
KW  - biomarkers
KW  - tumor markers
KW  - prognosis
KW  - heparanase
KW  - syndecan-1
KW  - heparan sulfate proteoglycans (HSPGs)
KW  - urothelial carcinoma
KW  - miRNA
KW  - quantitative PCR
KW  - tumor marker
KW  - voided urine cytology
KW  - KDM7A
KW  - histone demethylase
KW  - TC-E 5002
KW  - androgen receptor
KW  - drug resistance
KW  - non-invasive detection
KW  - telomerase
KW  - somatic mutations
KW  - TERT promoter region
KW  - muscle-invasive bladder cancer
KW  - chemotherapy
KW  - immunotherapy
KW  - personalized medicine
KW  - predictive biomarker
KW  - survivin
KW  - BIRC5
KW  - macrophage
KW  - KRT20
KW  - ERBB2
KW  - MIBC
KW  - prediction
KW  - RT-qPCR
KW  - adjuvant chemotherapy
KW  - survival
KW  - thema EDItEUR::M Medicine and Nursing
ER  -